Skip to content
mielomamultiplo.com · Multiple Myeloma
Emergency 112  · SNS 24 808 24 24 24
The Multiple Myeloma symbol — find out what it means

Multiple Myeloma There is hope. There is a way forward.

information · support · hope

It is always better to be an informed patient.

News, testimonies, a space to share ideas and links that help patients and carers understand the disease better and know where to find help.

Automatic translation by MielomaAI. The original text is in Portuguese. Some parts may still appear in Portuguese while they are being translated. Português
Overall summary of the last 24 hours

In the last 24 hours, several news items related to multiple myeloma have been released. In the US, the National Institutes of Health (NIH) shared data from the early stages of a treatment combining a bispecific antibody targeting BCMA for relapsed/refractory multiple myeloma. In Brazil, the state of Tocantins incorporated a high-cost medication into the treatment of this disease. In the US, a grant from Pfizer for multiple myeloma education was also announced. Furthermore, a retrospective study in the United States demonstrated that Photon-Counting Computed Tomography (CT) improves image quality and reduces radiation dose in patients with multiple myeloma. Another news item, with an unidentified origin, refers to a list of the 10 most important abstracts to be presented at ASH 2026, focusing on therapies such as CAR-T and Daratumumab. Additionally, Tempest Therapeutics acquired the rights to develop and commercialize an experimental treatment for multiple myeloma. Finally, a publication in the UK discussed the targeting of the NFIL3-MYC axis inhibition as a way to overcome therapy resistance in high-risk multiple myeloma.

Made by MielomaAI As of November 17, 2026, 3:22 PM. May contain errors: view the news and speak with your doctor.

Latest updates · interspersed sources
Latest News
Tratamentos
Next-Generation Multiple Myeloma Therapies Market to Reach

November 16 2026 Multiple myeloma treatment is expanding across antibody combinations CAR T cell therapies and newer immune modifying drugs Recent U S approvals have brought some options into earlier treatment lines while new subcutaneous formulations are changing how antibody ...

openPR.com · 16 nov 2026, 16:44
See all news →

Treatments

See all →

Research

See all →

Patients and associations

See all →

Access and public health

See all →
In the forum